Wang, L., Wang, Y., Chen, A., Teli, M., Kondo, R., Jalali, A., . . . Yokota, H. (2019). Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway. FASEB J.
Chicago Style aipamenaWang, Luqi, et al. "Pitavastatin Slows Tumor Progression and Alters Urine-derived Volatile Organic Compounds Through the Mevalonate Pathway." FASEB J 2019.
MLA aipamenaWang, Luqi, et al. "Pitavastatin Slows Tumor Progression and Alters Urine-derived Volatile Organic Compounds Through the Mevalonate Pathway." FASEB J 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.